Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1083-1097 , December 2006

Infectious myositis

  • Nancy F. Crum-Cianflone, MD, MPH, FACP (Staff, Infectious Disease Physician)

      Affiliations

    • Corresponding Author InformationTel.: +1 619 532 8134/40; Fax: +1 619 532 8137.

References 

  1. Wortmann RL. Inflammatory diseases of muscle and other myopathies. In:  Harris E,  Budd R, et al. editor. Kelley's Textbook of Rheumatology. 7th edn. Philadelphia: Saunders Elsevier; 2005;p. 1309–1335
  2. Christopher-Stine L, Plotz PH. Myositis: an update on pathogenesis. Current Opinion in Rheumatology. 2004;16:700–706
  3. Wadia NH, Katrak SM. Muscle infection: viral, parasitic, bacterial, and spirochetal. In:  Schapira AHV,  Griggs RC editor. Muscle Diseases. 1st edn. Boston: Butterworth Heinemann; 1999;p. 339–362
  4. Daley AJ, Atkinson M, Nallusamy R. Group A streptococcal myositis. Journal of Paediatrics and Child Health. 1999;35:588–590
  5. Ichinose K, Migita K, Sekita T, et al. Parvovirus B19 infection and myofasciitis. Clinical Rheumatology. 2004;23:184–185
  6. Eliasson H, Back E. Myositis and septicaemai caused by Francisella tularensis biovar holarctica. Scandinavian Journal of Infectious Diseases. 2003;5:510–511
  7. Wang JY, Lee LN, Hsueh PR, et al. Tuberculous myositis: a rare but existing clinical entity. Rheumatology. 2003;42:836–840
  8. Sharma M, Khatib R, Jones BA, Fakih MG. Cryptococcus neoformans myositis without dissemination. Scandinavian Journal of Infectious Diseases. 2002;34:858–859
  9. Behar DM, Ben-Ami H. Myositis accompanying Rickettsia conorii infection. The Israel Medical Association Journal. 2001;3:471–472
  10. Field AS, Marriott DJ, Milliken ST, et al. Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS. Journal of Clinical Microbiology. 1996;34:2803–2811
  11. Gave AA, Torres R, Kaplan L. Cryptococcal myositis and vasculitis: an unusual necrotizing soft tissue infection. Surgical Infections. 2004;5:309–313
  12. Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection. 2004;32:199–203
  13. Behan WM, Behan PO, Draper IT, Williams H. Does Toxoplasma cause polymyositis? Report of a case of polymyositis associated with toxoplasmosis and a critical review of the literature. Acta Neuropathologica. 1983;61:246–252
  14. Capo V, Despommier DD. Clinical aspects of infection with Trichinella spp. Clinical Microbiology Reviews. 1996;9:47–54
  15. Pasternack MS, Swartz MN. Myositis. In:  Mandel GL,  Bennett JE,  Dolin RD editor. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th edn. New York: Elsevier/Churchill Livingstone; 2005;p. 1194–1204
  16. Reimers CD, de Koning J, Neubert U, et al. Borrelia burgdorferi myositis: report of eight patients. Journal of Neurology. 1993;240:278–283
  17. Smith RD, Konoplev S, DeCourten-Myers G, Brown T. West Nile virus encephalitis with myositis and orchitis. Human Pathology. 2004;35:254–258
  18. Brook I. Microbiology and management of myositis. International Orthopaedics. 2004;28:257–260
  19. Hu JJ, Kao CL, Lee PI, et al. Clinical features of influenza A and B in children and association with myositis. Journal of Microbiology, Immunology, and Infection. 2004;37:95–98
  20. Plonquet A, Bassez G, Authier FJ, et al. Toxoplasmic myositis as a presenting manifestation of idiopathic CD4 lymphocytopenia. Muscle Nerve. 2003;27:761–765
  21. Solomon T, Ooi MH, Beasley DW, Mallewa M. West Nile encephalitis. British Medical Journal. 2003;326:865–869
  22. Horn CV, Master S. Pyomyositis tropicans in Uganda. East African Medical Journal. 1968;45:463–471
  23. Ansaloni L. Tropical pyomyositis. World Journal of Surgery. 1996;20:613–617
  24. Chiedozi LC. Pyomyositis. Review of 205 cases in 112 patients. American Journal of Surgery. 1979;137:255–259
  25. O'Neill DS, Baquis G, Moral L. Infectious myositis: a tropical disease steals out of its zone. Postgraduate Medicine. 1996;100:193–194199–200
  26. Crum NF. Bacterial pyomyositis in the United States. American Journal of Medicine. 2004;117:420–428
  27. Fowler A, Mackay A. Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user. Journal of Medical Microbiology. 2006;55:123–125
  28. Miyake H. Beitrage (Beitraege) zur Kenntnis der sogenannten Myositis Infectiosa. Mitteilungen aus den Grenzgebieten der Medizin und Chirurgie. 1904;13:155–198
  29. Smith IM, Vickers AB. Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936–1955). Lancet. 1960;1:1318–1322
  30. Schwartzman WA, Lambertus MW, Kennedy CA, Goetz MB. Staphylococcal pyomyositis in patients infected by the human immunodeficiency virus. American Journal of Medicine. 1991;90:595–600
  31. Widrow CA, Kellie SM, Saltzman BR, Mathur-Wagh U. Pyomyositis in patients with the human immunodeficiency virus: an unusual form of disseminated bacterial infection. American Journal of Medicine. 1991;91:129–136
  32. Chen W-S, Wan Y-L. Iliacus pyomyositis mimicking septic arthritis of the hip joint. Archives of Orthopaedic and Trauma Surgery. 1996;115:233–235
  33. Chusid MJ, Hill WC, Bevan JA, Sty JR. Proteus pyomyositis of the piriformis muscle in a swimmer. Clinical Infectious Diseases. 1998;26:194–195
  34. Wysoki MG, Angeid-Backman E, Izes BA. Iliopsoas myositis mimicking appendicitis: MRI diagnosis. Skeletal Radiology. 1997;26:316–318
  35. Walji S, Rubenstein J, Shannon P, Carette S. Disseminated pyomyositis mimicking idiopathic inflammatory myopathy. The Journal of Rheumatology. 2005;32:184–187
  36. Ruiz ME, Yohannes S, Wladyka CG. Pyomyositis caused by methicillin-resistant Staphylococcus aureus. New England Journal of Medicine. 2005;352:1488–1489
  37. Small LN, Ross JJ. Tropical and temperate pyomyositis. Infectious Disease Clinics of North America. 2005;19:981–989
  38. Van den Berge M, de Marie S, Kuipers T, et al. Psoas abscess: report of a series and review of the literature. The Netherlands Journal of Medicine. 2005;63:413–416
  39. Agrawal SN, Dwivedi AJ, Khan M. Primary psoas abscess. Digestive Diseases and Sciences. 2002;47:2103–2105
  40. Mallick IH, Thoufeeq MH, Rajendran TP. Iliopsoas abscesses. Postgraduate Medical Journal. 2004;80:459–462
  41. Gordin F, Stamler C, Mills J. Pyogenic psoas abscesses: noninvasive diagnostic techniques and review of the literature. Reviews of Infectious Diseases. 1983;5:1003–1011
  42. El-Masry S. Spontaneous gas gangrene associated with occult carcinoma of the colon: a case report and review of the literature. International Surgery. 2005;90:245–247
  43. Boenicke L, Maier M, Merger M, et al. Retroperitoneal gas gangrene after colonoscopic polypectomy without bowel perforation in an otherwise healthy individual: report of a case. Langenbeck's Archives of Surgery. 2006;391:157–160
  44. Kennedy CL, Krejany EO, Young LF, et al. The alpha-toxin of Clostridium septicum is essential for virulence. Molecular Microbiology. 2005;57:1357–1366
  45. Stevens DL, Maier KA, Mitten JE. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrobial Agents and Chemotherapy. 1987;31:213–218
  46. Stevens DL, Laine BM, Mitten JE. Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene cause by Clostridium perfringens. Antimicrobial Agents and Chemotherapy. 1987;31:312–316
  47. Stevens DL, Bryant AE, Adams K, Mader JT. Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clinical Infectious Diseases. 1993;17:231–237
  48. Wang C, Schwaitzberg S, Berliner E, et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Archives of Surgery. 2003;138:272–279
  49. Hart GB, Lamb RC, Strauss MB. Gas gangrene. The Journal of Trauma. 1983;23:991–1000
  50. Subramanian KN, Lam KS. Malignant necrotizing streptococcal myositis: a rare and fatal condition. The Journal of Bone and Joint Surgery. British Volume. 2003;85:277–278
  51. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. New England Journal of Medicine. 1989;321:1–7
  52. Adams EM, Gudmundsson S, Yocum DE, et al. Streptococcal myositis. Archives of Internal Medicine. 1985;145:1020–1023
  53. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. The Journal of Infectious Diseases. 1988;158:23–28
  54. Darenberg J, Ihendyane N, Sjolin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases. 2003;37:333–340
  55. Jahnson L, Berggren L, Bjorsell-Ostling E, et al. Streptococcal myositis. Scandinavian Journal of Infectious Diseases. 1992;24:661–665
  56. Johnson DA, Aulicino PL, Newby JG. Bacillus cereus-induced myonecrosis. The Journal of Trauma. 1984;24:267–270
  57. Heckerling PS, Stine TM, Pottage JC, et al. Aeromonas hydrophilia myonecrosis and gas gangrene in a nonimmunocompromised host. Archives of Internal Medicine. 1983;143:2005–2007
  58. Pozio E. New patterns of Trichinella infection. Veterinary Parasitology. 2001;98:133–148
  59. Pozio E, Sacchini D, Sacchi L, et al. Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clinical Infectious Diseases. 2001;32:638–642
  60. Wadia NH. Dissemianted cystericercosis: pseudohypertrophic muscular type. In:  Rose CF editors. Recent Advances in Tropical Neurology. 1st edn. Amsterdam: Elsevier; 1995;p. 119–130

PII: S1521-6942(06)00109-4

doi: 10.1016/j.berh.2006.08.005

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1083-1097 , December 2006

Article Tools